@Pharma_Tech profile picture
Pharma Tech @Pharma_Tech
Joined June 2009
  • Tweets 4,054
  • Following 245
  • Followers 1,409
Photos and videos
Ranbaxy to introduce malarial treatment Synriam in African nations bit.ly/1BXc32N
Novartis receives FDA approval for Signifor LAR to treat acromegaly bit.ly/1BXc32H
Boehringer starts patient enrolment in dabigatran Phase III trial to prevent ESUS: Boehringer Ingelheim has st... bit.ly/1wgkiXr
Acorda begins patient enrolment in Phase III trial of dalfampridine to treat PSWD: US-based biotechnology firm... bit.ly/13tWCnm
Novartis' Phase IIIb CLEAR trial of psoriasis drug Cosentyx meets endpoints: Swiss drug-maker Novartis has rep... bit.ly/13tWC75
Nanotherapeutics to acquire Baxter’s Vero cell vaccines platform bit.ly/1wcTeIr
Pfizer and OPKO collaborate to develop and commercialise hGH-CTP to treat GHD bit.ly/1wcTdEs
Fujifilm Diosynth Biotechnologies' UK Site Received Renewed MHRA Manufacturing Licence bit.ly/1Ad68p3
Boehringer reports positive results from LUX-Breast 1 and LUX-Breast 3 trials: Boehringer Ingelheim has report... bit.ly/12UNQ0I
Karyopharm begins Phase IIb trial of lymphoma drug selinexor: Karyopharm Therapeutics has started a registrati... bit.ly/12UNPtS
Better together? Combining therapies to slow down cancer growth bit.ly/1IR5AuV
Arno begins dosing in modified Phase I/II trial evaluating cancer drug onapristone: US-based biopharmaceutical... bit.ly/1x9GtQh
Alnylam begins Phase III ENDEAVOUR trial of revusiran in FAC patients: US-based Alnylam Pharmaceuticals has st... bit.ly/1Borgto
New Zealand approves Mylan-Abbott $5bn deal bit.ly/1IINQC4
UK reserves ready for Sierra Leone deployment to fight against Ebola bit.ly/1zYlhL1
Vetter Development Service Chicago Is Ready for Realising Clinical Syringe Projects bit.ly/1x6deOw
Pharma Technology Focus - Issue 32 bit.ly/1urU3Zi
BMS, Ono and Kyowa Hakko to conduct Phase I combination trial to treat cancers: Bristol-Myers Squibb (BMS), On... bit.ly/1zAhUeR
ContraVir begins pharmacokinetic trial of FV-100 to treat shingles: US-based ContraVir Pharmaceuticals has sta... bit.ly/1Go2jzi
Germany bans 80 generic drugs trialled at GVK Biosciences facility in India bit.ly/13bQuA5
Load more